LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $88.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Business Acquisitions | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Stock Repurchases | $2.0M | 2.2% |
| Other Financing | $5.6M | 6.3% |
| Other | $79.2M | 89.4% |
| Net Cash Flow | $1.9M | 2.1% |